Natixis Advisors LLC Boosts Stock Position in Corteva, Inc. (NYSE:CTVA)

Natixis Advisors LLC boosted its stake in Corteva, Inc. (NYSE:CTVA - Free Report) by 4.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,697,707 shares of the company's stock after purchasing an additional 70,400 shares during the period. Natixis Advisors LLC owned about 0.25% of Corteva worth $96,700,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Noble Wealth Management PBC bought a new stake in shares of Corteva in the fourth quarter worth about $26,000. Hager Investment Management Services LLC bought a new stake in shares of Corteva in the 4th quarter worth approximately $27,000. Golden State Wealth Management LLC purchased a new position in shares of Corteva during the fourth quarter valued at approximately $32,000. Centricity Wealth Management LLC bought a new position in shares of Corteva during the fourth quarter valued at approximately $34,000. Finally, First Financial Corp IN purchased a new stake in Corteva in the fourth quarter worth $35,000. Institutional investors own 81.54% of the company's stock.

Insider Activity at Corteva

In related news, insider Brian Titus sold 26,560 shares of the business's stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the completion of the sale, the insider now directly owns 11,347 shares in the company, valued at approximately $723,257.78. The trade was a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.20% of the stock is owned by company insiders.

Remove Ads

Corteva Stock Performance

NYSE:CTVA traded down $0.60 during mid-day trading on Thursday, reaching $61.86. The company's stock had a trading volume of 2,684,735 shares, compared to its average volume of 3,537,214. The firm's fifty day moving average price is $62.25 and its two-hundred day moving average price is $59.79. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. The stock has a market cap of $42.41 billion, a P/E ratio of 47.95, a PEG ratio of 1.68 and a beta of 0.79. Corteva, Inc. has a 12-month low of $50.01 and a 12-month high of $66.24.

Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. On average, equities analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.10%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva's payout ratio is currently 52.71%.

Wall Street Analyst Weigh In

CTVA has been the subject of several research reports. Royal Bank of Canada upped their price objective on shares of Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a report on Friday, February 7th. KeyCorp boosted their target price on shares of Corteva from $68.00 to $70.00 and gave the company an "overweight" rating in a report on Friday, February 7th. Wells Fargo & Company increased their price target on shares of Corteva from $67.00 to $73.00 and gave the stock an "overweight" rating in a research note on Tuesday, January 28th. Oppenheimer boosted their price objective on shares of Corteva from $70.00 to $72.00 and gave the stock an "outperform" rating in a research note on Friday, February 7th. Finally, BNP Paribas raised shares of Corteva to a "hold" rating in a research note on Monday, February 10th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, Corteva presently has an average rating of "Moderate Buy" and a consensus target price of $68.00.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.